- Home
- RCUS vs KSS Comparison
RCUS vs KSS Comparison
Compare RCUS & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- KSS
- Stock Information
- Founded
- RCUS 2015
- KSS 1962
- Country
- RCUS United States
- KSS United States
- Employees
- RCUS N/A
- KSS N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- KSS Department/Specialty Retail Stores
- Sector
- RCUS Health Care
- KSS Consumer Discretionary
- Exchange
- RCUS Nasdaq
- KSS Nasdaq
- Market Cap
- RCUS 906.4M
- KSS 931.8M
- IPO Year
- RCUS 2018
- KSS 1992
- Fundamental
- Price
- RCUS $10.40
- KSS $13.77
- Analyst Decision
- RCUS Buy
- KSS Sell
- Analyst Count
- RCUS 8
- KSS 14
- Target Price
- RCUS $20.71
- KSS $8.54
- AVG Volume (30 Days)
- RCUS 783.0K
- KSS 21.2M
- Earning Date
- RCUS 08-06-2025
- KSS 08-27-2025
- Dividend Yield
- RCUS N/A
- KSS 3.63%
- EPS Growth
- RCUS N/A
- KSS N/A
- EPS
- RCUS N/A
- KSS 1.09
- Revenue
- RCUS $262,000,000.00
- KSS $16,072,000,000.00
- Revenue This Year
- RCUS N/A
- KSS N/A
- Revenue Next Year
- RCUS $28.73
- KSS N/A
- P/E Ratio
- RCUS N/A
- KSS $12.64
- Revenue Growth
- RCUS 6.07
- KSS N/A
- 52 Week Low
- RCUS $6.50
- KSS $6.04
- 52 Week High
- RCUS $18.98
- KSS $21.39
- Technical
- Relative Strength Index (RSI)
- RCUS 63.56
- KSS 63.46
- Support Level
- RCUS $9.73
- KSS $10.85
- Resistance Level
- RCUS $10.23
- KSS $11.95
- Average True Range (ATR)
- RCUS 0.53
- KSS 0.82
- MACD
- RCUS 0.07
- KSS 0.18
- Stochastic Oscillator
- RCUS 82.11
- KSS 81.79
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.